An Extension Study of TAK-664 for Japanese People With Primary Immunodeficiency Disease
Clinical trial NCT04842643 · COMPLETED
Trial details
- NCT number
- NCT04842643
- Sponsor
- Takeda
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-27
- Primary completion
- 2024-04-25
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.